Biomed Central Ltd

SHERPA: Unknown

People

  1. Postow
    Postow
  2. Berger
    Berger
  3. Budhu
    Budhu
  4. Deasy
    Deasy
  5. Levine
    Levine
  6. Norton
    Norton
  7. Oh
    Oh
  8. Shen
    Shen
  9. Shia
    Shia
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (25)
  2. GSK Faculty (22)
  3. Solid Tumor Oncology Division (16)
  4. Melanoma and Immunotherapeutics Service (10)
  5. Population Sciences Research Program (9)
  6. Sloan Kettering Institute Postdocs (9)
  7. Surgery (9)
  8. Epidemiology and Biostatistics (8)
  9. Survivorship Research (8)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (7)
Search Within
  1. "2014"
Formats
  1. Journal Article (42)
  2. Meeting Abstract (11)
Groups
  1. Department of Medicine (25)
  2. GSK Faculty (22)
  3. Solid Tumor Oncology Division (16)
  4. Melanoma and Immunotherapeutics Service (10)
  5. Population Sciences Research Program (9)
  6. Sloan Kettering Institute Postdocs (9)

More Groups

People
  1. Jedd Wolchok (10)
  2. Michael Postow (4)
  3. Taha Merghoub (4)
  4. Daniel Sjoberg (3)
  5. Jianda Yuan (3)
  6. Jorge Reis-Filho (3)

More People

Years
  1. 2014 (53)
Publications
  1. Journal for ImmunoTherapy of Cancer (11)
  2. Genome Biology (6)
  3. BMC Cancer (4)
  4. Journal of Hematology & Oncology (4)
  5. BMC Bioinformatics (3)
  6. BMC Genomics (3)

More Publications

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mid-wall fibrosis on delayed enhancement CMR - A marker for adverse left ventricular chamber remodeling independent of cardiomyopathic etiology
    Meeting Abstract

    Kim, J.; Kochav, J. D.; Gurevich, S.; Horn, E. M.; Goyal, P.; Petashnick, M. M.; Afroz, A.; Okin, P. M.; Devereux, R. B.; Weinsaft, J. W.
    Journal of Cardiovascular Magnetic Resonance (2014)

    Fulltext@MSK | Save
  • Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Schaer, D.; Yang, X.; Zhong, H.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment
    Meeting Abstract

    Budhu, S.; Schaer, D.; Li, Y.; Houghton, A.; Silverstein, S.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Brahmer, J.; Balmanoukian, A.; Goldberg, S.; Ou, S. H.; Blake-Haskins, A.; Karakunnel, J.; Stockman, P.; Rizvi, N.; Antonia, S.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorlyimmunogenic tumors
    Meeting Abstract

    Zamarin, D.; Holmgaard, R. B.; Plitt, T.; Allison, J.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Patterns of long-term survival following Ipilimumab (Ipi): The Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
    Meeting Abstract

    Page, D. B.; Naidoo, J.; Momtaz, P.; Bogatch, K.; Kuk, D.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
    Meeting Abstract

    Hodi, F. S.; Ribas, A.; Daud, A.; Hamid, O.; Robert, C.; Kefford, R.; Hwu, W. J.; Gangadhar, T. C.; Joshua, A. M.; Hersey, P.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
    Meeting Abstract

    Postow, M.; Manuel, M.; Wong, P.; Yuan, J.; Noel, M.; Courtier, A.; Pasqual, N.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save